A product of Applied Basic Science Corporation

Clinical Research

Trust the Science


A great deal of test data and anecdotal evidence indicates that cannabinoids can provide animals with symptomatic relief from a range of medical conditions. Until now, however, there has been no rigorous scientific veterinary research.


Colorado State University College of Veterinary Medicine and Biomedical Sciences (CSU) is the first the institution in the nation to conduct veterinary cannabis clinical trials. These studies are sponsored by Applied Basic Science Corporation, the maker of CHO Pet Tincture, and will drastically alter the field of veterinary medicine and be a force for change in today's attitudes for best practices in veterinary medicine.


Our Partners: Pioneers in Their Fields of Expertise

CHO Pet Tincture was developed in partnership with some of the country’s leading experts in the medical use of cannabidiol (CBD) as well as in veterinary neurology.


Stephanie McGrath, DVM is an Assistant Professor at Colorado State University College of Veterinary Medicine and Biomedical Sciences and lead researcher on multiple clinical trials using CHO Pet Tincture. Board-certified in veterinary neurosurgery and neurology, Dr. McGrath is an expert in seizure disorders, inflammatory brain disease, and spinal cord injury.


Alan Shackelford, MD, is one of the nation’s leading medical experts on the medical use of CBD. Based at Amarimed of Denver, Colorado, he is an advisor to numerous companies, agencies and governments worldwide. Dr. Shackelford conducted his post-graduate medical training at the major teaching hospitals of the Harvard Medical School, including three fellowships.



Science Based and Proven Safe

Applied Basic Science Corporation (ABSC), the maker of CHO Pet Tincture, sponsored CSU’s Phase 1 Study to investigate the safety of specified combinations and delivery methods of cannabidiol (CSU) in dogs. Results confirming that dogs tolerated clinical doses of the compound found in CHO Pet Tincture without adverse effects were presented at the Institute of Cannabis Research Conference at CSU-Pueblo on April 29, 2017 and will be published in 2018.


Happening Now: Efficacy Studies for Epilepsy and Osteoarthritis

Multiple Phase 2 studies are currently underway at CSU using the compound found in CHO Pet Tincture. Research results should be published in 2018.

Learn More



Informing AVMA’s Policy on CBD

The results of CSU’s clinical trials using the compound found in CHO Pet Tincture are being closely watched by the American Veterinary Medical Association (AVMA) and will help inform their policies on CBD oil use.

Learn More



American Kennel Club/CSU Drug-Resistant Epilepsy Study

ABSC is the exclusive supplier of CBD oil to the American Kennel Club Canine Health Foundation trial studying drug-resistant epilepsy.

Learn More